Denver Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Denver Wealth Management's PFE Position: Q2 2026 in Review
Denver Wealth Management increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $14.5K and bringing the position to 14,745 shares worth $355K. The position accounts for 0.1% of the portfolio, ranked #77.
Denver Wealth Management first reported a position in PFE in Q1 2021 and has held it in 19 quarters since. The position peaked at $785K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Denver Wealth Management held 14,745 shares of Pfizer worth $355K as of Q2 2026.
- Denver Wealth Management bought 555 Pfizer shares in Q2 2026, an estimated $14.5K.
- Pfizer made up 0.1% of Denver Wealth Management's portfolio in Q2 2026, its #77 holding.
- Denver Wealth Management first reported a position in Pfizer in Q1 2021 and has held it in 19 quarters since.
- Denver Wealth Management's Pfizer position peaked at $785K in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Denver Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.